Shingles Vaccine Market to be valued over USD 9.74 Bn by 2030 - MDC Research
Market Data Centre
Market Data Centre

Shingles Vaccine Market By Product (Shingrix, and Zostavax), Patient Type (Pediatric Patients & Adult Patients) and Region (North America, Europe, Asia Pacific, and the Rest of the World (RoW)) - Global Analysis & Forecast 2022-2030

Pune, April 21, 2022 (GLOBE NEWSWIRE) -- A Shingles vaccine is a biological preparation that provides active acquired immunity to a particular disease. Vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like viruses or bacteria, which then keeps us safe from the diseases they cause. Vaccines are made using the disease-causing virus or bacteria, but in a form that will not harm human body.

The global Shingles Vaccine Market is estimated to be valued over USD 9.74 Bn by 2030, It is anticipated to reach a CAGR over 10.6% during the forecast period from 2022 to 2030.

Shingles Vaccine Market By Region

The global shingles market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). In 2018, North America accounted for the largest share in the global shingles vaccines, owing to availability of efficient healthcare insurance & reimbursement systems, better awareness, and favorable government regulations among others.



Download Sample PDF
https://www.marketdatacentre.com/samplepdf/104



COMPANY PROFILES
(Business Overview, Products Offered, Financial Performance*, Recent Developments)

  • GlaxoSmithKline plc.

  • Merck & Co., Inc.

  • SK chemicals

  • Green Cross Corp

  • CanSinoBIO

  • Geneone Life Science

  • Vaccitech

  • Among others

Vendor Assessment

Vendor assessment includes a deep analysis of how vendors are addressing the demand in the Shingles Vaccine Market. The MDC Competetive Scape model was used to assess qualitative and quantitative insights in this assessment. MDC's Competitive Scape is a structured method for identifying key players and outlining their strengths, relevant characteristics, and outreach strategy. MDC's Competitive Scape allows organizations to analyze the environmental factors that influence their business, set goals, and identify new marketing strategies. MDC Research analysts conduct a thorough investigation of vendors' solutions, services, programs, marketing, organization size, geographic focus, type of organization and strategies.

Technology Assessment

Technology dramatically impacts business productivity, growth and efficiency. Technologies can help companies develop competitive advantages, but choosing them can be one of the most demanding decisions for businesses. Technology assessment helps organizations to understand their current situation with respect to technology and offer a roadmap where they might want to go and scale their business. A well-defined process to assess and select technology solutions can help organizations reduce risk, achieve objectives, identify the problem, and solve it in the right way. Technology assessment can help businesses identify which technologies to invest in, meet industry standards, compete against competitors.